When Medical Weight Loss Falls Short

Managing obesity is difficult on multiple levels.

There are countless strategies, diets, exercise programs, behavioral coaching, and medications like GLP-1 receptor agonists (GLP-1 RAs) that promise progress. Early success can be motivating, but pushing through thresholds and sustaining weight loss can be more challenging than achieving results in the first place.

Medical weight loss programs are a viable option for short-term weight loss and improvements in health certain markers; in addition to shedding a few pounds, patients may be able to lower their blood sugar, reduce blood pressure, and improve energy levels.

But obesity is a chronic, biologically complex condition, and these strategies alone frequently aren’t enough to produce lasting change. For some patients, the scale eventually creeps back up, along with the health risks that come with it.

Medical weight loss isn’t to be discouraged, but it is wise to be realistic about its limitations. Recognizing when the time comes for a more definitive, durable solution allows patients to make informed decisions about their long-term health.

What is Medical Weight Loss?

Medical weight loss is comprehensive with structured protocols that go beyond simple exercise or fad dieting:

• Modifications to diet and exercise within a physician-supervised framework address root causes, such as hormonal imbalances or metabolism issues, to establish sustainable habits and prevent weight cycling.
• Behavioral support programs integrate coaching or counseling to help patients address emotional eating, establish routines, and cope with challenges that arise during their weight loss journey.
• Pharmacotherapy, such as GLP-1 RAs, is increasingly used as part of medical weight loss and works by reducing appetite, slowing gastric emptying, and helping patients feel full sooner. While they can produce exciting results in the short term, research shows that stopping the medication often leads to weight regain due to the body’s biological adaptations, including changes in appetite hormones and energy expenditure.¹

Medical weight loss programs can be highly effective for achieving initial weight loss. Still, without addressing the underlying metabolic dysfunction that is happening with obesity, these interventions are a form of management rather than a permanent fix.

Short-Term Benefits vs. Long-Term Limitations

The initial success of medical weight loss programs can be motivating and may even reduce some of the health risks associated with obesity. But maintaining these results over time can be challenging. Along with weight regain, improvements in blood sugar, blood pressure, and lipid profiles may also reverse once pharmacologic interventions and lifestyle modifications are discontinued.

Adherence to strict protocols can be difficult, and feelings of self-blame or shame when routines slip can further erode motivation. Patients often find it discouraging when their effort feels like a constant struggle, which can make it harder to stay on track with lifestyle programs or medication schedules. When it comes to GLP-1 medications, many patients do not remain on them for very long due to cost, side effects, access issues, or injection fatigue – more than half of patients discontinue GLP-1 therapy within one year, with discontinuation rates exceeding 70% by two years.²

Medical weight loss, more often than not, provides a temporary reset rather than a permanent solution. It’s important to consider options that address the underlying metabolic drivers of obesity rather than relying solely on interventions that require indefinite adherence to maintain results.

Biology and Metabolism

Even with all of the willpower one can muster, the body fights back. Why? Because obesity is a biologically complex condition. Our bodies have evolved to maintain a certain “set point” for weight, which is influenced by hormones, metabolism, and energy regulation.

When someone loses weight, the body responds by increasing hunger hormones (ghrelin), lowering satiety hormones (leptin and peptide YY), and reducing resting energy expenditure. In other words, the body becomes more efficient at conserving energy and prompts stronger feelings of hunger, all in an effort to regain the weight that was lost.³

Biological resistance helps explain why many patients regain weight after stopping medications or intensive lifestyle programs. It’s not a failure of discipline – that’s important to set straight. It’s the body’s natural defense against losing weight. Temporary interventions, even those that include GLP-1 medications or structured medical programs, often cannot overcome the body’s metabolic set point on their own.

For more durable results, an approach that fundamentally recalibrates these biological systems, such as bariatric surgery, can become necessary. Surgery changes how the body regulates appetite, energy balance, and metabolism, creating a more sustainable foundation for long-term weight loss.

Evidence-Based Obesity Care

Bariatric surgery is a clinically proven, evidence-based tool that addresses the underlying issues that make sustained weight loss so difficult.

Procedures such as gastric bypass, sleeve gastrectomy, duodenal switch, or single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) restrict stomach capacity, alter gut hormones, and produce lasting effects on appetite, satiety, and energy balance. More often than not, early results are striking – many patients experience considerable weight loss within the first year, exceeding what medications alone can deliver.

Bariatric surgery also produces remarkable improvements in comorbid conditions. Patients frequently see remission of type 2 diabetes, reductions in blood pressure and cholesterol, and improvements in sleep apnea and joint pain.

As mentioned before, medical weight loss programs are not to be discouraged. Diet, exercise, and behavioral therapy are actually integral aspects of post-operative bariatric care – the benefit lies in timing. Before surgery, these strategies can contribute to temporary weight management and reduced surgical risk. After surgery, lifestyle modifications and behavioral interventions are essential for maintaining metabolic changes, correcting obesity-related health conditions, and perpetuating weight loss.

Bariatric surgery is the gold standard for reliable, long-term weight loss, especially in patients with class II and III obesity. At Bariatric Specialists of the Carolinas, we’ll guide you through a personalized surgical plan that aligns with your goals and lifestyle. Start your journey to sustainable weight loss and improved well-being by scheduling a consultation.

1. Kolli, R. T., Aoutla, S., Jyothi, N., Mohamed Kalifa, M. R. H., Raju, A., & Cheenikkal Muralidharan, K. (2025). Rebound or Retention: A Meta-Analysis of Weight Regain After the Discontinuation of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Other Anti-obesity Drugs. Cureus, 17(10), e94926. https://doi.org/10.7759/cureus.94926.
2. American Society for Metabolic and Bariatric Surery. (2025, June 17). Head-to-head Study Shows Bariatric Surgery Superior to GLP-1 Drugs for Weight Loss. American Society for Metabolic and Bariatric Surgery. https://asmbs.org/news_releases/head-to-head-study-shows-bariatric-surgery-superior-to-glp-1-drugs-for-weight-loss/.
3. Kolli, R. T., Aoutla, S., Jyothi, N., Mohamed Kalifa, M. R. H., Raju, A., & Cheenikkal Muralidharan, K. (2025). Rebound or Retention: A Meta-Analysis of Weight Regain After the Discontinuation of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Other Anti-obesity Drugs. Cureus, 17(10), e94926. https://doi.org/10.7759/cureus.94926.